MedTrace Logo

Neuroendocrine Neoplasm Based on Multi-omics Integrated Analysis

NCT04931446 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-06-18

No results posted yet for this study

Summary

This project intends to analyze the molecular biological characteristics of NEN based on multi-omics, develop an exclusive NEN multi-omics big data platform, and carry out molecular subtypes and potential targets prediction, so as to improve the therapeutic effect of neuroendocrine tumors.

Conditions

  • Neuroendocrine Neoplasm

Interventions

PROCEDURE

Biopsy/surgical tissue and peripheral blood

Retrieve specimens stored in the tissue bank, the main types of samples are RNAlater specimens, liquid nitrogen frozen specimens and peripheral blood specimens

Sponsors & Collaborators

  • Xian-Jun Yu

    lead OTHER

Principal Investigators

  • Xianjun Yu, MD, PhD · Fudan University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-31
Primary Completion
2022-03-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04931446 on ClinicalTrials.gov